Primary Site Surgery and Survival Impact in Metastatic HER2-Amplified Breast Cancer: Responsible use of Cohort Data

Ann Surg Oncol. 2020 Oct;27(10):3570-3572. doi: 10.1245/s10434-020-08868-x. Epub 2020 Jul 22.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms* / enzymology
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / surgery
  • Cohort Studies
  • Female
  • Humans
  • Neoplasm Metastasis
  • Receptor, ErbB-2* / genetics
  • Receptor, ErbB-2* / metabolism
  • Survival Rate

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2